| 1 | tap® tartaric acid spheres | | | | | | | 2 | 0.61% |
| 2 | hydroxide powders magnesium hydroxide | | | | | | | 2 | 0.61% |
| 3 | magnesium hydroxide pastes and | | | | | | | 2 | 0.61% |
| 4 | hydroxide pastes and gels | | | | | | | 2 | 0.61% |
| 5 | dietary supplements orally disintegrating | | | | | | | 1 | 0.31% |
| 6 | lozenges excipients for effervescents | | | | | | | 1 | 0.31% |
| 7 | excipients for effervescents ingredients | | | | | | | 1 | 0.31% |
| 8 | for effervescents ingredients for | | | | | | | 1 | 0.31% |
| 9 | effervescents ingredients for antacids | | | | | | | 1 | 0.31% |
| 10 | ingredients for antacids and | | | | | | | 1 | 0.31% |
| 11 | digestive aids ingredients for | | | | | | | 1 | 0.31% |
| 12 | aids ingredients for mineral | | | | | | | 1 | 0.31% |
| 13 | ingredients for mineral supplements | | | | | | | 1 | 0.31% |
| 14 | for mineral supplements ingredients | | | | | | | 1 | 0.31% |
| 15 | mineral supplements ingredients for | | | | | | | 1 | 0.31% |
| 16 | spi pharma locations request | | | | | | | 1 | 0.31% |
| 17 | for chewable tablets and | | | | | | | 1 | 0.31% |
| 18 | orally disintegrating technology oral | | | | | | | 1 | 0.31% |
| 19 | disintegrating technology oral drug | | | | | | | 1 | 0.31% |
| 20 | delivery plasticizers for softgel | | | | | | | 1 | 0.31% |
| 21 | plasticizers for softgel capsules | | | | | | | 1 | 0.31% |
| 22 | for softgel capsules tastemasking | | | | | | | 1 | 0.31% |
| 23 | softgel capsules tastemasking vaccine | | | | | | | 1 | 0.31% |
| 24 | adjuvants capabilities pharmasolutions technical | | | | | | | 1 | 0.31% |
| 25 | capabilities pharmasolutions technical service | | | | | | | 1 | 0.31% |
| 26 | pharmasolutions technical service customer | | | | | | | 1 | 0.31% |
| 27 | service data packages regulatory | | | | | | | 1 | 0.31% |
| 28 | data packages regulatory expertise | | | | | | | 1 | 0.31% |
| 29 | packages regulatory expertise cgmp | | | | | | | 1 | 0.31% |
| 30 | regulatory expertise cgmp compliance | | | | | | | 1 | 0.31% |
| 31 | expertise cgmp compliance insights | | | | | | | 1 | 0.31% |
| 32 | supplements orally disintegrating technology | | | | | | | 1 | 0.31% |
| 33 | excipients for chewable tablets | | | | | | | 1 | 0.31% |
| 34 | events company careers locations | | | | | | | 1 | 0.31% |
| 35 | pharma locations request samples | | | | | | | 1 | 0.31% |
| 36 | compressol® sm pharmasolutions ultraburst™ | | | | | | | 1 | 0.31% |
| 37 | sm pharmasolutions ultraburst™ stab™ | | | | | | | 1 | 0.31% |
| 38 | pharmasolutions ultraburst™ stab™ preformulation | | | | | | | 1 | 0.31% |
| 39 | for tablets digestive aid | | | | | | | 1 | 0.31% |
| 40 | tablets digestive aid actives | | | | | | | 1 | 0.31% |